Chainalysis: Leading peptide grey market suppliers shift to Bitcoin and stablecoins

CoinFeed reported on June 5th that, according to The Block, a recent report from Chainalysis shows that as the gray market for peptide compounds used for purposes such as weight loss and anti-aging explodes, leading sellers are turning to Bitcoin and stablecoins for transactions. In the first quarter of 2026, the value of cryptocurrencies flowing into this sector increased by 159% quarter-over-quarter, reaching $32 million. Chainalysis points out that the annualized size of the peptide market has exceeded $100 million, with cryptocurrencies becoming the mainstay of payments as traditional banks and credit card institutions prohibit the trading of prescription-grade compounds. Leading sellers are demonstrating more sophisticated on-chain financial operations, typically relying on Bitcoin and stablecoins. Sellers with daily deposits exceeding $1,000 have stablecoins dominating their asset portfolios, possibly to mitigate the volatility of the crypto market.